Search
for

    Sort by

    Research 901–930 of 1000+

    1. Multi-Herbal Extracellular Vesicle and Growth Factor Serum for Eyelash Care: A Pilot Randomized, Double Blind, Placebo-Controlled Clinical Study medRxiv · 2026
    2. Effects of topical Royal jelly extract on hair quantity and quality of individuals with self-perceived hair thinning: A randomized double-blind placebo-controlled trial Clinical Traditional Medicine and Pharmacology · 2026
    3. Efficacy and safety of topical siRNA-based formulation targeting DKK-1 in androgenetic alopecia: A randomized, double-blind, vehicle-controlled trial Journal of the American Academy of Dermatology · 2026
    4. Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study Clinical Cosmetic and Investigational Dermatology · 2026
    5. 75333 Effect of Increasing Fluence of Low-Level Laser Therapy for Treatment of Androgenetic Alopecia - a Double-Blinded Randomized Sham-Controlled Trial Journal of the American Academy of Dermatology · 2026
    6. Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial Journal of the American Academy of Dermatology · 2026
    7. A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Ashwagandha Root Extract Capsule on Skin and Hair Health in Healthy Adults. PubMed · 2026
    8. Low-Molecular-Weight Collagen Peptides Improve Hair Health in Adults with Damaged Hair: A Randomized, Double-Blind, Placebo-Controlled Trial International Journal of Peptide Research and Therapeutics · 2026
    9. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    10. Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study 2026
    11. Amaranthus Extract Promotes Healthy Follicles and Anagen Hair Density-A Randomized Placebo-Controlled, Double-Blinded Study. PubMed · 2025
    12. Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study International Journal of Women’s Dermatology · 2025
    13. 61720 The effect of sublingual minoxidil on androgenetic alopecia in transgender individuals receiving testosterone for gender-affirmation: A 24-week single-centre double-blinded, randomized, placebo-controlled clinical trial Journal of the American Academy of Dermatology · 2025
    14. Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain Annals of Medicine · 2025
    15. Recovery Effects of Oral Supplementation with Polar Lipid-Rich Wheat Extracts on Acute Telogen Effluvium: A Randomized Double-Blind Placebo-Controlled Study Clinical Cosmetic and Investigational Dermatology · 2025
    16. Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study 2025
    17. Oral Spermidine Supplementation Prolongs Hair Follicle Anagen Phase with Sustained Effects: A Randomized, Double-Blind, Placebo-Controlled Trial MEDS Public Health and Preventive Medicine · 2025
    18. Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study 2025
    19. Evaluation of the Efficiency of Low-Level Laser Therapy in Female Patients with Chronic Pelvic Pain: A Double-Blind, Randomized, Placebo-Controlled Clinical Study Surgery and Clinical Practice · 2024
    20. Skin health promoting effects of a proprietary nutraceutical ingredient (SesZen-BioTM): a placebo controlled, double-blind, and randomized clinical study International Journal of Research in Dermatology · 2024
    21. COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF TOPICAL METHOTREXATE WITH TRETINOIN VERSUS BETAMETHASONE WITH TRETINOIN IN PATIENTS OF ALOPECIA AREATA: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY Asian Journal of Pharmaceutical and Clinical Research · 2024
    22. 724 - A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled study to evaluate the efficacy and safety of rezpegaldesleukin in adults with severe to very-severe alopecia areata British Journal of Dermatology · 2024
    23. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Journal of neurogastroenterology and motility · 2024
    24. A Single Intradermal Injection of Autologous Adipose-Tissue-Derived Stem Cells Rejuvenates Aged Skin and Sharpens Double Eyelids Journal of personalized medicine · 2023
    25. Efficacy of an Oral Ageratum Conyzoides Formulation on Increasing Hair Growth and Decreasing Hair Loss in Males and Females: A Randomised Double-Blind Placebo-Controlled Study Trichology and cosmetology: · 2023
    26. FASCE, the benefit of spironolactone for treating acne in adult females: study protocol for a randomized double-blind trial 2020
    27. FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial 2020
    28. Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial DOAJ (DOAJ: Directory of Open Access Journals) · 2017
    29. Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product Journal of The American Academy of Dermatology · 2014
    30. Efficacy of topical nanoemulsion (NB-002) for the treatment of distal subungual onychomycosis: A randomized, double-blind, vehicle-controlled trial Journal of The American Academy of Dermatology · 2010